Investments
2Portfolio Exits
1Latest Ryan Sarver News
Jan 21, 2021
I was first introduced to Andrew Dudum , the CEO of Hims & Hers, in 2016 by Atomic’s Chester Ng . I was instantly impressed by Andrew’s energy, charisma and unbounded ambition. A year later Medha Agarwal , Ryan Sarver and I were sitting in Andrew’s office diving deeper into the vision for Hims & Hers and hearing about the initial success of the launch just weeks earlier. The three of us walked away extremely excited by Andrew’s passion for broadly redefining healthcare and knew we had to move fast. The very next day the entire Redpoint partnership cleared our calendars and went to the Atomic office in the Presidio to meet with the Hims & Hers team. At the end of the meeting, we asked for a few minutes to discuss the investment — all of us were truly inspired by what the team was building and knew we needed to be part of the Hims & Hers journey. After Andrew came back into the conference room we shared with him our enthusiasm for the team, the vision and the market opportunity. We surprised him with a manilla envelope inside of which was a signed, peach color (the Hims & Hers brand color) term sheet in the signature Hims & Hers font. The smile on his face suggested we hit upon a core emotion and connected with his appreciation of design. That was the start of our journey together. Hims & Hers was just an eight-person team at that point, treating hundreds of patients per day. Since then, the team has scaled to enabling over two million medical visits while continuing to innovate and expand the product portfolio. In just this past year alone, Hims & Hers has added everything from mental health services to primary care to access to one of the first, at-home saliva based tests for Covid authorized by the FDA under an emergency use authorization. Today is an exciting day as Hims & Hers becomes a public company. It still feels like the early days. We’re excited to continue on this journey and see the impact Hims & Hers will continue to have on redefining health and wellness as a public company. Stay tuned!
Ryan Sarver Investments
2 Investments
Ryan Sarver has made 2 investments. Their latest investment was in SmartThings as part of their Seed VC on December 12, 2012.
Ryan Sarver Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
12/4/2012 | Seed VC | SmartThings | $3M | Yes | A-Grade, Aaron Levie, Alexis Ohanian, BoxGroup, Brainchild Holdings, Chris Dixon, David Tisch, Emil Michael, First Round Capital, Jared Hecht, Lerer Hippeau, Loic Le Meur, Martin Varsavsky, Matt Mullenweg, Max Levchin, Nathan Hanks, Slow Ventures, Start Fund, Steve Martocci, SV Angel, Tuesday Capital, Vivi Nevo, and Zorik Gordon | 1 |
10/26/2012 | Seed VC |
Date | 12/4/2012 | 10/26/2012 |
---|---|---|
Round | Seed VC | Seed VC |
Company | SmartThings | |
Amount | $3M | |
New? | Yes | |
Co-Investors | A-Grade, Aaron Levie, Alexis Ohanian, BoxGroup, Brainchild Holdings, Chris Dixon, David Tisch, Emil Michael, First Round Capital, Jared Hecht, Lerer Hippeau, Loic Le Meur, Martin Varsavsky, Matt Mullenweg, Max Levchin, Nathan Hanks, Slow Ventures, Start Fund, Steve Martocci, SV Angel, Tuesday Capital, Vivi Nevo, and Zorik Gordon | |
Sources | 1 |
Ryan Sarver Portfolio Exits
1 Portfolio Exit
Ryan Sarver has 1 portfolio exit. Their latest portfolio exit was SmartThings on August 15, 2014.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
8/15/2014 | Acquired | 1 |
Date | 8/15/2014 |
---|---|
Exit | Acquired |
Companies | |
Valuation | |
Acquirer | |
Sources | 1 |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.